FLT3LG and rectal cancer: In a cohort of patients with high-risk rectal cancer, higher circulating levels of Flt3L were associated with better PFS [51] and in a prospective trial on neoadjuvant hepatic arterial infusion of colorectal cancer liver metastasis, early increases in Flt3L predicted improved recurrence free survival following subsequent surgery [52].